The landscape of dementia analysis has advanced substantially with the advent of complex biomarkers, such as amyloid PET scans, tau imaging, and blood-centered tests that could detect Alzheimer's pathology decades prior to signs or symptoms arise. Whilst these technological improvements characterize outstanding progress in comprehension neurodegene